Delisting riskPopularity #3,749
Lucid Diagnostics (LUCD)
Commercializes EsoGuard testing on esophageal cells collected with EsoCheck.
$0.8926
After hours+0.01 (+1.00%)
At close$0.8838(+4.58%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 30.37% | 61.73M shares | |
|---|---|---|---|
| 118 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 4.68% | 9.50M shares | |
| 10 holders · as of Apr 13, 2026 | |||
| Other | ≈ 64.95% | 132.01M shares | |
| remainder | |||
203.24M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
118 holders · 61.73M shares · 27 new positions · 86 increased · 13 reduced · 12 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 8.86M | 4.36% | +8.86Mnew | Aug 14, 2026 |
| BlackRock, Inc. | 8.37M | 4.12% | +3.73M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 6.56M | 3.23% | +2.40M | Aug 13, 2026 |
| Two Seas Capital LP | 6.00M | 2.95% | +3.00M | Aug 12, 2026 |
| Masters Capital Management LLC | 4.00M | 1.97% | 0 | Aug 14, 2026 |
| Abrdn PLC | 3.82M | 1.88% | +178.7K | Jul 31, 2026 |
| Geode Capital Management, LLC | 3.79M | 1.86% | +1.54M | Aug 12, 2026 |
| State Street Corp | 2.44M | 1.20% | +882.8K | Aug 7, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| PAVmed Inc. | 27.50% | 38.82M | 13D | Feb 9, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| May 20, 2026 | Dennis Matheisdirector | Purchase | 245,000 | $1.00 | 1,033,443 |
House and Senate disclosures
Not reported.